Concepedia

Publication | Open Access

Phase II Study of Erlotinib in Advanced Non–Small-Cell Lung Cancer After Failure of Gefitinib

DOIFull Paper Access

148

Citations

34

References

2007

Year

Byoung Chul Cho, Chong-Kun Im, Moo Suk Park, Joon Chang, Jong Pil Park, Hye Jin Choi, Yu Jin Kim, Sang Joon Shin, Joohyuk Sohn, Hoguen Kim,
Journal of Clinical Oncology

Abstract

Erlotinib seems to be a potential therapeutic option for the treatment of advanced NSCLC patients with wild-type EGFR who had SD while receiving gefitinib.

References

YearCitations

Page 1